301017.SHE ShuYu Civilian Pharmacy Corp. Ltd.
- Market cap
- CNY 5.62B
- P/E
- 55.4x
- P/B
- 2.67x
- ROE
- 2.5%
- Dividend yield
- 1.61%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 301017.SHE undervalued?
Graham number301017.SHE trades 156.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ShuYu Civilian Pharmacy Corp. Ltd. fundamental analysis
No fundamental analysis for ShuYu Civilian Pharmacy Corp. Ltd. yet.
ShuYu Civilian Pharmacy Corp. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ShuYu Civilian Pharmacy Corp. Ltd.
ShuYu Civilian Pharmacy Corp., Ltd. engages in the pharmaceutical retail chain business in China. It also involved in the pharmaceutical wholesale business. The company was founded in 1999 and is based in Jinan, China.
Full company profileShuYu Civilian Pharmacy Corp. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ShuYu Civilian Pharmacy Corp. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 3.47B | 4.64B | 5.32B | 7.82B | 9.19B | 9.57B | 10.3B | 10.6B |
| Gross Profit | 1.15B | 1.40B | 1.52B | 2.24B | 2.60B | 2.43B | 2.70B | 2.81B |
| Operating Income | 163M | 329M | 186M | 418M | 339M | 24.7M | 224M | 290M |
| EBITDA | 244M | 344M | 444M | 767M | 806M | 409M | 712M | 225M |
| Net Income | 111M | 216M | 115M | 229M | 133M | -189M | 114M | 51.6M |
| EPS | 0.30 | 0.59 | 0.28 | 0.57 | 0.33 | -0.47 | 0.28 | 0.13 |
| Balance Sheet | ||||||||
| Total Assets | 2.44B | 3.48B | 5.00B | 7.86B | 9.33B | 9.27B | 9.41B | 9.70B |
| Total Liabilities | 1.12B | 1.95B | 3.09B | 5.60B | 6.97B | 7.15B | 7.11B | 7.45B |
| Shareholders' Equity | 1.32B | 1.52B | 1.89B | 2.23B | 2.29B | 2.04B | 2.13B | 2.10B |
| Cash & Short-term Investments | 458M | 564M | 622M | 1.86B | 1.40B | 1.40B | 1.24B | 1.46B |
| Cash Flow | ||||||||
| Operating Cash Flow | 123M | 234M | 238M | 148M | 143M | 489M | 803M | - |
| Capital Expenditure | 115M | 194M | 137M | 110M | 182M | 174M | 172M | 45.0M |
| Free Cash Flow | 7.51M | 40.5M | 101M | 38.0M | -38.6M | 316M | 631M | 42.4M |
| Ratios | ||||||||
| ROE | 8.4% | 14.2% | 6.1% | 10.3% | 5.8% | -9.3% | 5.4% | 2.5% |
| ROA | 4.6% | 6.2% | 2.3% | 2.9% | 1.4% | -2.0% | 1.2% | 0.5% |
| Net Profit Margin | 3.2% | 4.7% | 2.2% | 2.9% | 1.4% | -2.0% | 1.1% | 0.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ShuYu Civilian Pharmacy Corp. Ltd. dividends
- Dividend yield
- 1.61%
- Forward dividend
- 0.05 CNY
- Payout ratio
- 79.0%
- Ex-dividend date
- Jun 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 90.3M | 0.22 | 79.0% |
| 2024 | CNY 103M | 0.25 | - |
| 2023 | CNY 107M | 0.26 | 80.5% |
| 2022 | CNY 69.9M | 0.17 | 30.5% |
| 2021 | CNY 55.7M | 0.14 | 48.5% |
| 2020 | CNY 21.3M | 0.06 | 9.8% |
| 2019 | CNY 21.0M | 0.06 | 18.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns ShuYu Civilian Pharmacy Corp. Ltd.
- Insiders 71.77%
- Institutions 1.12%
- Public & others 27.11%
- Shares outstanding 406M
- Free float 127M
ShuYu Civilian Pharmacy Corp. Ltd. company profile
- Company name
- ShuYu Civilian Pharmacy Corp. Ltd.
- Ticker
- 301017.SHE
- ISIN
- CNE100004LT4
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Employees
- 15,933
- Fiscal year end
- December
- Address
- No. 56 Shanda North Road, Jinan, China, 250100
- Phone
- 86 531 6995 7162
- Website
- shuyupingmin.com
About ShuYu Civilian Pharmacy Corp. Ltd.
ShuYu Civilian Pharmacy Corp., Ltd. engages in the pharmaceutical retail chain business in China. It also involved in the pharmaceutical wholesale business. The company was founded in 1999 and is based in Jinan, China.
ShuYu Civilian Pharmacy Corp. Ltd. management
4- Ms. Guangxia QinPresident & Director · born 1971
- Mr. Qinhong HuFinancial Director · born 1972
- Mr. Qiang LiVP, Board Secretary & Director · born 1979
- Fang FangAccounting Supervisor